IMNM (immunome.com) Bozor qiymatining balans qiymatiga nisbati
Immunome, Inc. (IMNM) kompaniyasining istiqbollari antitelalarni yaratish samaradorligi bilan belgilanadi, bu esa startapni bozor sikllaridan mustaqil qiladi, aktivlar qiymati esa 4.04 miqdorida qolmoqda. Foyda ko'rish asosi korporativ sog'liqni saqlash gigantlari bilan ittifoq tuzgan holda biofarmatsevtika patentlarining uzoq muddatli amal qilish muddati orqali shakllantirilgan. Ushbu narxlar grafigi yagona pudratchiga bog'lanib qolmasdan, saratonga qarshi kurashni kengaytirish uchun tashqi laboratoriya tarmog'ini rivojlantirish strategiyasini tasdiqlaydi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_IMNM_-_Immunome-Inc._-_Market-Capitalization-to-Net-Assets "IMNM Immunome Bio Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Immunome Inc (IMNM) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunome Corp|IMNM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Immunome Corp|IMNM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Immunome
Kompaniyaning dastlabki tahlili:Immunome, Inc. - IMNM
Emitent ishonchliligini tekshirishda ushbu ko'rsatkich kompaniyaning bozor qiymatini uning sof aktivlariga solishtiradi, bunda 4.04 qiymati balans hisobotiga nisbatan joriy premium yoki diskontni aks ettiradi. Immunome, Inc. (IMNM) kompaniyasining joriy bozor kapitalizatsiyasining balans hisobotiga nisbatini tahlil qilish, bozor ADC terapiyasi va radioligandlar sohalaridagi Immunome, Inc. (IMNM) R&D loyihalari kelgusidagi muvaffaqiyatini qanchalik darajada baholayotganini aniqlash imkonini beradi.
Asosiy raqobatchilar
ARGX (argenx SE) - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Rigel Pharma RIGL|Bozor kapitallashuvining balans qiymatiga nisbati ANAB (AnaptysBio Corp)|ATXS: Balans qiymatiga nisbatan bozor kapitallashuvi|ENGN (enGene Holdings Inc.) - Bozor qiymatining balans qiymatiga nisbati|RAPT (rapt.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati JBIO|Kapitallashuvning sof aktivlarga nisbati Aclaris Therapeutics Inc. (ACRS)|Kapitallashuvning sof aktivlarga nisbati KYTX|Bozor kapitallashuvining balans qiymatiga nisbati TLSA (Tiziana Life Sciences, Ltd.)|CABA - Bozor qiymatining balans qiymatiga nisbati|ventyxbio.com - Kapitallashuvning balans qiymatiga nisbati|THTX (Theratechnologies) - Bozor qiymatining balans qiymatiga nisbati|AVTX: Bozor qiymatining balans qiymatiga koeffitsiyenti|ELDN (Eledon) - Bozor qiymatining balans qiymatiga nisbati|Agenus, Inc (AGEN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CLYM (Climb Bio Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti zurabio.com (ZURA)|aTyr Pharma (ATYR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati adagene.com (ADAG)|Bozor kapitallashuvining balans qiymatiga nisbati IMA|Shattuck Labs Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|Equillium Bio (EQ) - Bozor qiymatining balans qiymatiga nisbati|CNTB - Kapitallashuvning balans qiymatiga nisbati|IMUX (immunic-therapeutics.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Atara Bio|IFRX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi X4 Pharmaceuticals, Inc|ACET (Adicet Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CELU (celularity.com)|INmune Bio - Bozor qiymatining balans qiymatiga nisbati|Barinthus Biotherapeutics PLC - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences, Inc (KZR) - Bozor qiymatining balans qiymatiga nisbati|SABS: Kapitallashuvning balans qiymatiga nisbati|AKTX (Akari Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|ENLV (Enlivex Therapeutics Ltd.) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc QTTB|Sof aktivlarga nisbatan bozor kapitallashuvi GeoVax Labs|Edesa (EDSA) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|xtlbio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Bolt Bio (BOLT)|HCWB: Balans qiymatiga nisbatan bozor qiymati|APVO (aptevotherapeutics.com) - Bozor qiymatining balans qiymatiga nisbati|aimimmuno.com (AIM) - Kapitallashuvning sof aktivlarga nisbati|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati gribio.com (GRI)|XORTX Therapeutics (XRTX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati REVB|Indaptus Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|SCNI: Bozor qiymatining balans qiymatiga nisbati|CALI: Kapitallashuvning sof aktivlarga nisbati|AFMD (affimed.com) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Allakos|HOOK (HOOKIPA Pharma, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGMS|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics ITOS|Kapitallashuvning balans qiymatiga nisbati oceanbiomedical.com (OCEA)|TCBP: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Third Harmonic Bio Inc. THRD